论文部分内容阅读
目的:分析经尿道前列腺等离子电切手术治疗前列腺的临床疗效。方法:选取2011年1月~2013年10月于我院治疗148例前列腺增生患者为研究对象,采用英国Gyrus公司等离子双极电切设备治疗前列腺增生。记录患者术前、术后1个月膀胱残余尿量、最大尿流率、国际前列腺症状评分分值以及术后电切综合征发生率。结果:经自身术前、术后1个月比较,术后患者膀胱残余尿量明显低于术前,P<0.01,有极显著性差异。术后最大尿流率与术前比较也有明显改善,P<0.05,有显著性差异。国际前列腺症状评分术后明显低于术前P<0.05具有显著差异。术后电切综合征发生率极低。结论:应用经尿道前列腺等离子电切手术治疗前列腺,临床疗效好,安全性高,值得临床推广及应用。
Objective: To analyze the clinical efficacy of transurethral resection of prostate by prostatectomy. Methods: From January 2011 to October 2013, 148 patients with benign prostatic hyperplasia were treated in our hospital. Prostatic hyperplasia was treated by bipolar plasma cutting equipment from UK Gyrus Company. Preoperative and postoperative 1 month bladder residual urine volume, maximum flow rate, international prostate symptom score score and the incidence of postoperative resection syndrome were recorded. Results: Compared with preoperative and postoperative one month after operation, residual urine volume in postoperative patients was significantly lower than that before operation (P <0.01), with significant difference. Postoperative maximal urinary flow rate and preoperative comparison also significantly improved, P <0.05, there was a significant difference. International Prostate Symptom Score was significantly lower than preoperative P <0.05 significant difference. The incidence of postoperative resection syndrome is very low. Conclusion: Transurethral resection of the prostate by prostatectomy has good clinical curative effect and high safety. It is worthy of clinical application and promotion.